Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.88M | $ 2.36M | $ 4.65M | $ 7.42M | $ 3.57M |
| Gross Profit | $ 3.88M | $ 957.00K | $ 1.58M | $ -35.12M | $ -39.10M |
| Operating Income | $ -154.54M | $ -115.23M | $ -71.24M | $ -63.35M | $ -55.03M |
| EBITDA | $ -139.03M | $ -104.20M | $ -66.08M | $ -45.64M | $ -49.67M |
| Net Income | $ -141.43M | $ -122.78M | $ -70.51M | $ -59.78M | $ -50.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 423.60M | $ 304.95M | $ 408.25M | $ 194.42M | $ 64.38M |
| Total Assets | $ 465.63M | $ 352.74M | $ 444.65M | $ 235.84M | $ 122.93M |
| Total Debt | $ 2.54M | $ 4.03M | $ 3.04M | $ 3.48M | $ 3.66M |
| Net Debt | $ -32.27M | $ -25.40M | $ -36.10M | $ -40.35M | $ -7.58M |
| Total Liabilities | $ 36.46M | $ 26.53M | $ 25.18M | $ 26.48M | $ 28.91M |
| Stockholders' Equity | $ 429.17M | $ 326.20M | $ 419.48M | $ 209.36M | $ 94.03M |
| Cash Flow | |||||
| Free Cash Flow | $ -109.11M | $ -105.56M | $ -62.16M | $ -41.96M | $ -47.15M |
| Operating Cash Flow | $ -107.29M | $ -103.73M | $ -60.91M | $ -40.40M | $ -46.41M |
| Investing Cash Flow | $ -105.78M | $ 89.94M | $ -216.16M | $ -98.22M | $ 17.08M |
| Financing Cash Flow | $ 218.46M | $ 4.08M | $ 272.37M | $ 171.23M | $ 16.26M |